The inventors look forward to the moves of India’s Warren Buffett, Rakesh Jhunjhunwala. Whatever additions or alterations he makes in his portfolio, it becomes a piece of news.
Well, in the initial three months of 2021, i.e., January-March he again went on to make some fine-tuning to his existing portfolio.
Let us see what were those changes and learn about Rakesh Jhunjhwala’s portfolio.
As of March 31, 2021, the top 10 stocks in the portfolio of Rakesh Jhunjhunwala are:
He holds a total of 38 stocks in his portfolio and these stocks are worth more than Rs 16,483.5 crores. Out of these stocks, one of such stocks that turned eyes was Fortis Healthcare.
But, why Fortis Healthcare stocks became the star of Rakesh Jhunjhunwala’s portfolio in the March quarter?
Find out in the next section.
The COVID-19 vaccines and other reasons pushed the healthcare stocks in the past couple of months. During the March quarter, various mutual funds also sold their stake in Fortis Healthcare stock particularly.
Not only the mutual funds but in the span of three months i.e between January- March, the Big Bull also went on to increase his stake in Fortis Healthcare.
Whereby by the end of the December 2020 quarter, he and his wife Rekha Jhunjhunwala held a total of 3.97% in Fortis Healthcare then by the end of March quarter he held a total of 4.31% of this stock. Currently, his portfolio has a total of 3,25,50,000 shares of Fortis Healthcare company and these shares have a total of Rs 652.95 crores.
The direct impact of this fine-tuning done by Rakesh Jhunjhunwala benefitted Fortis Healthcare share price. By far, its share price has jumped by 29%. Apart from this, the Domestic Institutional Investors seems to have followed the footpath of Rakesh Jhunjhunwala as they also went on to increase their stakes in Fortis Healthcare during the first three months of 2021.
Fortis Healthcare is one of the leading firms in the healthcare services industry. The integrated services provided by it includes clinics, ancillary services and quaternary care facilities.
Being one of the largest healthcare organisations in India, it is listed on both NSE and BSE. So, let us have a look at the company financials (and related graphs) in order to have a better understanding of its performance.
In the span of the last 5 years, the revenue of the company has increased at a rate of 3.47% and that of the healthcare service industry has surged by 13.67%.
Between 2016-2020, the market share of Fortis Healthcare reduced from 22.17% to 13.82%
In the last 5 years, the debt to equity ratio of the company has been around 30.7% and the current ratio stood at 66.52%.
Hope you enjoyed reading the highlights of Rakesh Jhunjhunwala’s portfolio. For more such interesting content stay tuned with Convey!